Tonix Pharmaceuticals Holding (TNXP) Total Current Liabilities (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Total Current Liabilities for 17 years, with the latest figure at $30.8 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 61.51% year-over-year to $30.8 million in Q2 2026; TTM through Jun 2026 was $30.8 million, a 61.51% increase from a year earlier, with the FY2025 full-year figure at $30.8 million, up 68.44% from the prior year.
• Total Current Liabilities was $30.8 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $29.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $30.8 million in Q4 2025, with the low at $12.1 million in Q1 2025.
• Average Total Current Liabilities over 5 years is $19.5 million, with a median of $18.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 154.71% in 2022, then sank 40.69% in 2025.
• Over 5 years, Total Current Liabilities stood at $18.2 million in 2022, then advanced by 3.87% to $18.9 million in 2023, then dropped by 3.06% to $18.3 million in 2024, then jumped by 68.44% to $30.8 million in 2025, then retreated by 0.17% to $30.8 million in 2026.
• The last three Total Current Liabilities figures came in at $30.8 million (Q2 2026), $29.6 million (Q1 2026), and $30.8 million (Q4 2025), per Business Quant data.